SCHEMBL20157523

SCHEMBL20157523

O=CCc1ccc(C(=O)c2ccc(F)cc2)c(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
S1PR1 P21453 1/20 0.38
PTPN1 P18031 1/20 0.38
ATM Q13315 1/20 0.38
LTA4H P09960 1/20 0.37
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
SRD5A2 P31213 1/20 0.36
PRNP P04156 1/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157560 0.85 PTPN1 (0.43) CES2CES1S1PR1PTPN1LTA4H
SCHEMBL11831342 0.85 MAPT (0.44) CES2CES1ATMMAPTMAPK1
SCHEMBL20157516 0.84 ALDH1A1 (0.48) CES2CES1LMNASMN1; SMN2HTT
SCHEMBL11860220 0.81 LTA4H (0.46) CES2CES1PTPN1LTA4HLMNA
SCHEMBL20157757 0.80 LMNA (0.50) CES2CES1S1PR1PTPN1ABL1
SCHEMBL21351905 0.79 CA2 (0.41) S1PR1LMNASMN1; SMN2HTTMAPT
SCHEMBL21362538 0.79 SRD5A2 (0.39) CES2CES1S1PR1LMNASMN1; SMN2
SCHEMBL21362568 0.79 EPHX2 (0.41)
SCHEMBL20157557 0.79 PTPN1 (0.39) CES2CES1S1PR1PTPN1LMNA
SCHEMBL21362418 0.78 THRA (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed